Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Immunology | Pediatrics/Neonatology | Vaccines
Clinical Trials: Vaccines
A listing of clinical trials currently looking for volunteers to enroll in Vaccines studies. Click on the closest city to find more detailed information on a research study in your area.
Alabama
Birmingham : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Daphne : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Arizona
Chandler : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Mesa : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Tucson : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Arkansas
Jonesboro : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Little Rock : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
California
Paramount : Center for Clinical Trials, LLC
SHINE Study: We're looking for young adults to volunteer a clinical research study exploring new immunization options for meningococcal diseases like meningitis.
View More »
Fresno : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Hayward : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Huntington Beach : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Loma Linda : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Moreno Valley : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Paramount : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Sacramento : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
San Diego : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Valley Village : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Colorado
Denver : Radiant Research - Denver
Meningitis Vaccine Research Study
Longmont : Longmont Medical Research Network
Investigational Combination Vaccine Study for Ages 4 through 6
View More »
Colorado Springs : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Denver : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Connecticut
Norwich : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Florida
Miami : Research Site
Healthy Volunteers of All Ages Needed
Pinellas Park : Radiant Research - St. Petersburg
Clinical Research for Flu Vaccine
Pinellas Park : Radiant Research - St. Petersburg
Flu Vaccine Research Study
Pinellas Park : Radiant Research - St. Petersburg
Flu Vaccine Research Study
Tampa : Tampa Clinical Research
Family trip to Asia? Mosquitoes spread the disease Japanese Encephalitis all over Asia. Your child(or the child of someone you know) may be eligible to participate in a research study being conducted by Passport Health and Tampa Clinical Research.
View More »
Tampa : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Georgia
Atlanta : Radiant Research - Atlanta
Meningitis Vaccine Research Study
View More »
Atlanta : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Dalton : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Marietta : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Woodstock : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Idaho
Meridian : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Illinois
DeKalb : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Iowa
Council Bluffs : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Kansas
Prairie Village : CTT Research
Flu Vaccine Trial
Wichita : Wichita Clinic, PA
Clinical Research Trial studying Rheumatoid Arthritis Therapy and Vaccines
View More »
Augusta : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Wichita : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Kentucky
Lexington : Central Kentucky Research Associates
Melanoma Vaccine
View More »
Bardstown : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Louisville : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Massachusetts
Michigan
Stevensville : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Minnesota
Edina : Radiant Research - Minneapolis
Vaccine Research
View More »
Saint Pail : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Saint Paul : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Missouri
St. Louis : Radiant Research - St. Louis
A Clinical Research Study for Meningitis Vaccine (People 56+)
St. Louis : Radiant Research - St. Louis
Clinical Research for Vaccine (Measles, Mumps, Rubella)
St. Louis : Radiant Research - St. Louis
Flu Vaccine Research Study
View More »
Kansas City : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Saint Louis : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
St. Louis : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Nebraska
Fremont : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Lincoln : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Omaha : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Nevada
Henderson : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
New Jersey
Edison : Anderson & Collins Clinical Research, Inc.
Are you at least 65 years old? Are you planning to get a FLU VACCINE this year?
New York
Mineola : Winthrop University Hospital Clinical Trials Center
Pediatric Meningococcal Vaccine
Mineola : Winthrop University Hospital Clinical Trials Center
Preventative vaccine
View More »
East Syracuse : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Syracuse : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
North Carolina
Cary : PMG Research of Cary
Flu Vaccine Coming in October
Cary : PMG Research of Cary
Healthy Volunteers Needed for Vaccine Research Study
Charlotte : PMG Research of Charlotte
Flu Vaccine Coming in October
Charlotte : Piedmont Medical Research
The Flu Stinks, So Protect Yourself!
Charlotte : PMG Research of Charlotte
The Flu Stinks, So Protect Yourself!
Hickory : PMG Research of Hickory
Flu Vaccine Coming in October
Raleigh : PMG Research of Raleigh
Attention: Men and Women age 65 years and older are invited to participate in a Flu Vaccine Research Study.
Raleigh : PMG Research of Raleigh
Flu Vaccine Coming in October
Raleigh : Wake Research Associates Updated
Study of MMR Vaccine for Children
Salisbury : PMG Research of Salisbury
Flu Vaccine Coming in October
Wilmington : PMG Research of Wilmington
Clostridium Difficile Vaccine: Do You Have An Upcoming Surgery Scheduled?
Wilmington : PMG Research of Wilmington
Flu Vaccine Coming in October
Wilmington : PMG Research of Wilmington
Research Volunteers Needed
Winston-Salem : PMG Research of Winston-Salem
Flu Vaccine Coming in October
View More »
Durham : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Raleigh : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
North Dakota
Fargo : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Ohio
Akron : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Cincinnati : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Cleveland : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Columbus : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Huber Heights : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
View More »
Kettering : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Oklahoma
Norman : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Oklahoma City : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Tulsa : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Pennsylvania
Rhode Island
Cranston : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Warwick : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
South Carolina
Anderson : Radiant Research - Anderson
Flu Vaccine Research Study
Anderson : Radiant Research - Anderson
Meningitis Vaccine (Pediatric) Research Study
Anderson : Radiant Research - Anderson
What's News @ Radiant Research Anderson
Mt Pleasant : Coastal Carolina Research Center
Flu Vaccine Study - Aged 65 years of age or older? Volunteers needed for an investigational flu vaccine research study.
Mt Pleasant : Coastal Carolina Research Center
Pandemic Bird Flu Vaccine Research Study - Healthy Volunteers aged 18 to 64
View More »
Anderson : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Charleston : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Mount Pleasant : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Tennessee
Bristol : PMG Research of Bristol
Attention: Men and Women age 65 years and older are invited to participate in a Flu Vaccine Research Study.
Knoxville : PMG Research of Knoxville
Flu Vaccine Coming in October
Nashville : Clinical Research Associates, Inc.
Adolescent Vaccine Study
Nashville : Clinical Research Associates, Inc.
Flu Vaccine
View More »
Bristol : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Nashville : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Texas
Houston : DM Clinical Research
An investigational vaccine study that would limit the amount of shots given.
Houston : DM Clinical Research
Pediatric Meningitis Vaccine- Houston,TX
Houston : DM Clinical Research
Pediatric RSV Vaccine- Houston,TX
San Antonio : Lung Diagnostics, LTD
Research study of an investigational vaccine for prevention of Herpes Zoster (Shingles)
View More »
Austin : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Dallas : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Houston : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
San Antonio : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Tomball : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Utah
Bountiful : Pharmaceutical Research Organization
If you have a healthy child 9 months to 15-18 months, we invite you to see if he or she may qualify for a medical research study to determine how the Menactra vaccine interacts with Pentacel.
Murray : Radiant Research - Salt Lake City
Meningitis Research Study
Salt Lake City : J. Lewis Research, Inc.
MMR Vaccine (12-15 months)
Salt Lake City : J. Lewis Research, Inc.
Research study of a Hepatitis B vaccine in adults 20 to 49 years of age, with or without Type 2 Diabetes
South Jordan : J. Lewis Research, Inc.
Meningitis Vaccine
South Jordan : Jordan River Family Medicine
MMR Vaccine
South Jordan : J. Lewis Research, Inc.
MMR Vaccine
View More »
Murray : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Salt Lake City : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
South Jordan : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
West Jordan : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Virginia
Charlottesville : Charlottesville Medical Research
Meningococcal vaccine
View More »
Burke : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Charlottesville : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Washington
Vancouver : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Wisconsin
La Crosse : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Monroe : Pfizer Investigational Site
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age
Canada
Montreal : Pfizer Investigational Site
A Study to Assess the Safety and Tolerability of Different Doses of PF-05402536 and PF-06413367 in Healthy Adult Smokers.
Sherbrooke : Pfizer Investigational Site
A Study to Assess the Safety and Tolerability of Different Doses of PF-05402536 and PF-06413367 in Healthy Adult Smokers.
Toronto : Pfizer Investigational Site
A Study to Assess the Safety and Tolerability of Different Doses of PF-05402536 and PF-06413367 in Healthy Adult Smokers.
